103 related articles for article (PubMed ID: 26189014)
1. Comparing the reimbursement of new medicines between Australia and New Zealand.
Ragupathy R; Babar ZU
Aust Health Rev; 2016 Feb; 40(1):118-119. PubMed ID: 26189014
[No Abstract] [Full Text] [Related]
2. Author reply: exploring the implications of a fixed budget for new medicines: a study of reimbursement of new medicines in Australia and New Zealand.
Taylor CB; Wonder M
Aust Health Rev; 2016 Feb; 40(1):120. PubMed ID: 26254890
[No Abstract] [Full Text] [Related]
3. Exploring the implications of a fixed budget for new medicines: a study of reimbursement of new medicines in Australia and New Zealand.
Taylor C; Wonder M
Aust Health Rev; 2015 Sep; 39(4):455-461. PubMed ID: 25751688
[TBL] [Abstract][Full Text] [Related]
4. Access to new medicines in New Zealand compared to Australia.
Wonder M; Milne R
N Z Med J; 2011 Nov; 124(1346):12-28. PubMed ID: 22143849
[TBL] [Abstract][Full Text] [Related]
5. Cost of pharmaceutical benefits.
Mackereth MB
N Z Med J; 1988 Jul; 101(849):460-1. PubMed ID: 3399187
[No Abstract] [Full Text] [Related]
6. Response to PHARMAC on Access to new medicines in New Zealand compared to Australia.
Milne R; Wonder M
N Z Med J; 2011 Dec; 124(1347):91-3. PubMed ID: 22237576
[No Abstract] [Full Text] [Related]
7. Can we afford all this?
Dickerson JF
Time; 2003 Dec; 162(23):48-51. PubMed ID: 14712554
[No Abstract] [Full Text] [Related]
8. [Changes of drug reimbursement expenses incurred by National Health Fund in Silesian voivodeship in the period of 1999-2004].
Swistak P; Dzielicki M; Janiec R; Błońska-Fajfrowska B
Wiad Lek; 2005; 58(9-10):495-9. PubMed ID: 16529058
[TBL] [Abstract][Full Text] [Related]
9. Industry warily eyes new Medicare drug plan.
Vastag B
Nat Biotechnol; 2006 Feb; 24(2):120. PubMed ID: 16465141
[No Abstract] [Full Text] [Related]
10. Medicare prescription drug coverage (part D): challenges and opportunities.
Witten B
Nephrol News Issues; 2006 Aug; 20(9):14-6, 18. PubMed ID: 16916055
[No Abstract] [Full Text] [Related]
11. Do drug copayments work?
David J
CMAJ; 1994 May; 150(9):1491-3. PubMed ID: 8168015
[No Abstract] [Full Text] [Related]
12. Pharmaceutical Benefits Scheme.
Louis WJ; O'Callaghan CJ; Krum H; Mander AG; Louis ES
Med J Aust; 1994 Jul; 161(2):174. PubMed ID: 8028551
[No Abstract] [Full Text] [Related]
13. Comparing prescription drug plans. New choices made available by Medicare Part D deserve serious study.
AVMA Group Health & Life Insurance Trust
J Am Vet Med Assoc; 2005 Dec; 227(12):1884-5. PubMed ID: 16382541
[No Abstract] [Full Text] [Related]
14. HEW promotes wider use of generic drugs, predicts savings under reimbursement plan.
Hospitals; 1979 Feb; 53(3):17. PubMed ID: 759296
[No Abstract] [Full Text] [Related]
15. Dispensing in general practice. Overhaul system of reimbursement.
McCormack T
BMJ; 1993 Jun; 306(6894):1748. PubMed ID: 8343635
[No Abstract] [Full Text] [Related]
16. [Effects of the Health Structure Regulation on prescribing behavior of established physicians].
Güther B
Gesundheitswesen; 1995 Apr; 57(4):185-91. PubMed ID: 7787368
[TBL] [Abstract][Full Text] [Related]
17. "Tough but fair"? The active management of the New Zealand drug benefits scheme by an independent Crown agency.
Davis P
Aust Health Rev; 2004 Nov; 28(2):171-81. PubMed ID: 15527397
[TBL] [Abstract][Full Text] [Related]
18. Trends in prescribing--the dawn of DUSC.
Med J Aust; 1990 May; 152(9):504. PubMed ID: 2381352
[No Abstract] [Full Text] [Related]
19. Drug utilisation.
McManus P
Med J Aust; 1993 May; 158(10):724. PubMed ID: 8487712
[No Abstract] [Full Text] [Related]
20. Medicaid drug programs.
McGovern J
Nurs Homes; 1980; 29(1):30-1. PubMed ID: 10297673
[No Abstract] [Full Text] [Related]
[Next] [New Search]
